This episode is shared from Mayo Clinic Q&A and was recorded in February, 2021

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest: Gregory A. Poland, M.D. (@DrGregPoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

When it comes to the COVID-19 pandemic, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, says there's some good news. "Case numbers are falling, masking and distancing do work, and we can control this if we do it right."

However, the not so good news is that variants are showing up in over 30 countries and are reportedly more transmissible. There also seems to be a reduction in vaccine efficacy against the new variants.

"This is a desperate race between vaccine and virus, between time and opportunity, and we dare not lose that opportunity," emphasizes Dr. Poland.

In this Mayo Clinic Q&A podcast, Dr. Poland discusses how COVID-19 viruses mutate into new variants. He also discusses recent COVID-19 research conducted by the NFL, plus he touches on the future of individualized vaccines. "I can see the development of a coronavirus vaccine against multiple types of coronavirus, including the one that causes the common cold, and very likely combine that with the influenza vaccine."

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

COVID-19 Miniseries Episode 62: Mayo Clinic Q&A: COVID-19 Virus, Variants and Vaccines Update

Mayo Clinic Talks

COVID-19 Miniseries Episode 62: Mayo Clinic Q&A: COVID-19 Virus, Variants and Vaccines Update